← Back to Search

Prevention (Elasto Gel Therapy Mittens and Foot Wraps) for Breast Cancer

N/A
Waitlist Available
Led By Pooja P Advani
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Absence of sensory peripheral neuropathy, skin or nail disorders at the start of treatment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months post chemotherapy
Awards & highlights

Study Summary

This trial is investigating whether cryotherapy can help prevent or improve taxane-induced peripheral neuropathy in breast cancer patients.

Eligible Conditions
  • Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You do not have any nerve, skin or nail problems before starting the treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months post chemotherapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months post chemotherapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Peripheral neuropathy (PN)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prevention (Elasto Gel Therapy Mittens and Foot Wraps)Experimental Treatment2 Interventions
Patients wear Elasto Gel Therapy Mittens and Foot Wraps on both hands and feet 15 minutes prior to each infusion, during the entire infusion, and for 15 minutes after the completion of each infusion during their three months of treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medical Device Usage and Evaluation
2021
N/A
~150

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,552 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,333 Patients Enrolled for Breast Cancer
Mayo ClinicLead Sponsor
3,176 Previous Clinical Trials
3,757,957 Total Patients Enrolled
83 Trials studying Breast Cancer
14,036 Patients Enrolled for Breast Cancer
Pooja P AdvaniPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research endeavor open at the present moment?

"Clinicaltrials.gov data reveals that this medical trial, which initially opened for enrolment on January 23rd 2020, is no longer actively seeking patients. Nonetheless, there are presently 2,745 other clinical trials welcoming participants to participate in their studies."

Answered by AI

Does this trial accept individuals aged 45 or older?

"According to the predetermined eligibility requirements, potential participants must be at least 18 years old and should not exceed 99."

Answered by AI

To whom does the criteria of this experimental research extend?

"80 volunteers aged between 18 and 99, suffering from peripheral neuropathy are needed for this trial. The following prerequisites must be met: diagnosis of breast cancer; 4-6 cycles of paclitaxel or docetaxel administered every 3 weeks over 12-18 week period; no sensory peripheral neuropathy, skin or nail issues upon starting treatment; Eastern Cooperative Oncology Group performance status rating of 0 to 2; self completion (or help with) questionnaires capability as well as signature provided on informed consent form."

Answered by AI
~19 spots leftby Mar 2025